ResearcherFujian Medical UniversityNo recent work listed
Shanshan Huang
Matched on ORCID iD 0000-0001-6706-5894; OpenAlex author ID A5061561457. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 5
- LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.16480↗
- MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3. Co-author DOI 10.1016/j.prp.2019.01.026↗
- BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. Co-author DOI 10.5301/ijbm.5000310↗
- Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/1010428317699131↗
- Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1007/s13277-015-4675-5↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianping Xiong · 2 shared papers, 2019–2021 · strength 0.26
- Xuenong Ouyang · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Xiong Chen · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Jiawei Zheng · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Yu-Fang Huang · 2 shared papers, 2016–2018 · strength 0.14
- Yin Yin · 2 shared papers, 2016–2017 · strength 0.13
- Junhe Li · 1 shared paper, 2021 · strength 0.12
- Jun Chen · 1 shared paper, 2021 · strength 0.12
- Yan Zhang · 1 shared paper, 2017 · strength 0.06
- Song Li · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.